Long-term Follow-up of Covid-19 Patients in Their Home Environment After Hospitalization in a Covid Department or Intensive Care Unit
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Health related Quality of life (general well-being) questionnaire
研究概览
简要总结
In this monocentric, prospective and descriptive trial we want to evaluate the long-term consequences for patients treated for Covid-19. Covid patients who were hospitalized for min. 5 days either in a Covid-19 department or in intensive care unit will be followed-up for 8 weeks after hospital discharge. This is done via an innovative electronic platform in the home environment (UZA@home). On the one hand the quality of life, rehabilitation and reintegration of the patient will be evaluated and on the other hand the patient will be screened for various psychosocial aspects such as anxiety, depression and post-traumatic stress syndrome.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males and females
- •Adult age
- •Hospitalization with proven Covid-19 infection with a minimum stay of 5 days
- •Signed Informed Consent
排除标准
- •The patient does not have a smartphone or computer with internet connection.The patient is not sufficiently skilled in entering data via a digital interface. This degree of skill is estimated by the research doctor or nurse.
- •Patient in a palliative setting (DNR 2 or higher outside of COVID condition
- •The patient does not speak the Dutch language
结局指标
主要结局
Health related Quality of life (general well-being) questionnaire
时间窗: 8 weeks after hospital discharge
Evaluation of Quality of Life after hospitalization due to COVID-19 infection using the EQ-5D-5L questionnaire
次要结局
- Depression and/or anxiety(3 times after hospital discharge: first at week 0, second time at week 4, third time 8 weeks after discharge)
- Revalidation & Reintegration(daily, up to 8 weeks after hospital discharge)
- Post traumatic stress syndrome(8 weeks after hospital discharge)
研究者
Davina Wildemeersch
MD
University Hospital, Antwerp